Bioactivity:

USL311 is a CXCR4 receptor antagonist which prevents the binding of stromal-cell derived factor-1 (SDF-1 or CXCL12) to CXCR4. USL311 inhibits CXCR4 activation and decreases proliferation and migration of CXCR4-expressing tumor cells, with anti-tumor activ

CAS nr:

1373268-67-7

Purity:

98%

Molecular Weight:

422,57

SMILES:

CC(C)N1CCC(CC1)N1CCCN(CC1)c1cccc(n1)C(=O)Nc1ccncc1

Formula:

C24H34N6O

Pathway:

Autophagy,Immunology/Inflammation,GPCR/G Protein

Target:

CXCR,CXCR,CXCR